Social isolation reduces mammary development, tumor incidence, and expression of epigenetic regulators in wild-type and p53-heterozygotic mice

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 620-629

  Hasen, Nina S ^a,b   O'Leary, Kathleen A ^b   Auger, Anthony P ^a   Schuler, Linda A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR 54; MESSENGER RNA; METHYL BINDING PROTEIN 2; PROGESTERONE RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESTRUS CYCLE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HYPOTHALAMUS; MEDIAL PREOPTIC AREA; MORPHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; SOCIAL ISOLATION; SOCIAL STRESS; WEANING; WILD TYPE;

ANIMALS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; INCIDENCE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952073110     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0225     Document Type: Article

References (57)

1. Duijts SF, Zeegers MP, Borne BV. The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 2003;107:1023-1029. (Pubitemid 37429846)
2. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of biobehavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240-248.
3. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-282. (Pubitemid 37267857)
4. Sephton SE, Dhabhar FS, Keuroghlian AS, et al. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav Immun 2009;23:1148-1153.
5. Pierce BL, Ballard-Barbash R, Bernstein L, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009;27:3437-3444.
6. Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat 2005;92:97-105. (Pubitemid 40933573)
7. Paul K, Boutain D, Agnew K, Thomas J, Hitti J. The relationship between racial identity, income, stress and C-reactive protein among parous women: implications for preterm birth disparity research. J Natl Med Assoc 2008;100:540-546. (Pubitemid 351717366)
8. Taylor TR, Williams CD, Makambi KH, et al. Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study. Am J Epidemiol 2007;166:46-54.
9. Hermes GL, McClintock MK. Isolation and the timing of mammary gland development, gonadarche, and ovarian senescence: implications for mammary tumor burden. Dev Psychobiol 2008;50:353-360.
10. Hermes GL, Delgado B, Tretiakova M, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A 2009;106:22393-22398.
11. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939-944.
12. Bennett CN, Green JE. Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models. Breast Cancer Res 2008;10:213.
13. Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 2005;29:799-804. (Pubitemid 40755465)
14. Brower V. Cancer disparities: disentangling the effects of race and genetics. J Natl Cancer Inst 2008;100:1126-1129.
15. Palanza P, Gioiosa L, Parmigiani S. Social stress in mice: gender differences and effects of estrous cycle and social dominance. Physiol Behav 2001;73:411-420. (Pubitemid 32595716)
16. Royds JA, Iacopetta B. p53 and disease: when the guardian angel fails. Cell Death Differ 2006;13:1017-1026. (Pubitemid 43753492)
17. Lozano G, Zambetti GP. What have animal models taught us about the p53 pathway? J Pathol 2005;205:206-220.
18. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7. (Pubitemid 2027671)
19. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice. Oncogene 2003;22:4664-4674. (Pubitemid 36976441)
20. Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 2007;80:84-97.
21. Paxinos G, Franklin KBJ. The mouse brain in steriotaxic coordinates. San Diego: Academic Press; 2001.
22. McBride WJ, Schultz JA, Kimpel MW, et al. Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non- preferring (NP) and Wistar rats: a proteomics study. Pharmacol Biochem Behav 2009;92:304-313.
23. Kurian JR, Forbes-Lorman RM, Auger AP. Sex difference in mecp2 expression during a critical period of rat brain development. Epigenetics 2007;2:173-178.
24. Palanza P. Animal models of anxiety and depression: how are females different? Neurosci Biobehav Rev 2001;25:219-233.
25. Williams JB, Pang D, Delgado B, et al. A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev Res 2009;2:850-861.
26. Ibarguen-Vargas Y, Surget A, Touma C, Palme R, Belzung C. Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal. Psychoneuroendocrinology 2008;33:1357-1368.
27. Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A 2006;103:2196-2201. (Pubitemid 43271646)
28. Imagawa W, Bandyopadhyay GK, Nandi S. Regulation of mammary epithelial cell growth in mice and rats. Endocr Rev 1990;11:494-523.
29. Conneely OM, Jericevic BM, Lydon JP. Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2003;8:205-214. (Pubitemid 38129942)
30. Roa J, Vigo E, Castellano JM, et al. Hypothalamic expression of KiSS-1 system and gonadotropin-releasing effects of kisspeptin in different reproductive states of the female rat. Endocrinology 2006;147:2864-2878. (Pubitemid 43764622)
31. Murphy KG. Kisspeptins: regulators of metastasis and the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 2005;17:519-525.
32. Kinsey-Jones JS, Li XF, Knox AM, et al. Down-regulation of hypothalamic kisspeptin and its receptor, Kiss1r, mRNA expression is associated with stress-induced suppression of luteinising hormone secretion in the female rat. J Neuroendocrinol 2009;21:20-29.
33. Horn HF, Vousden KH. Coping with stress: multiple ways to activate p53. Oncogene 2007;26:1306-1316.
34. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-310.
35. Allain DC. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2008;10:383-395.
36. Green JE, Shibata MA, Yoshidome K, et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial targeting with multistage progression to carcinoma. Oncogene 2000;19:1020-1027.
37. Whitten WK. Modification of the oestrous cycle of the mouse by external stimuli associated with the male. J Endocrinol 1956;13:399-404.
38. Whitten WK. Occurrence of anoestrus in mice caged in groups. J Endocrinol 1959;18:102-107.
39. Shepherd T, Hassell JA. Role of Ets transcription factors in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia 2001;6:129-140. (Pubitemid 33640651)
40. LaMarca HL, Rosen JM. Minireview: hormones and mammary cell fate-what will I become when I grow up? Endocrinology 2008;149:4317-4321.
41. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J. Hormone dependence in premalignant mammary progression. Cancer Res 2003;63:1067-1072. (Pubitemid 36278440)
42. Koolhaas JM. Coping style and immunity in animals: making sense of individual variation. Brain Behav Immun 2008;22:662-667.
43. Charbonneau AM, Mezulis AH, Hyde JS. Stress and emotional reactivity as explanations for gender differences in adolescents' depressive symptoms. J Youth Adolesc 2009;38:1050-1058.
44. Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways. Clin Exp Metastasis 2003;20:11-18.
45. Tena-Sempere M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol 2010;314:164-169.
46. Knox AM, Li XF, Kinsey-Jones JS, et al. Neonatal lipopolysaccharide exposure delays puberty and alters hypothalamic Kiss1 and Kiss1r mRNA expression in the female rat. J Neuroendocrinol 2009;21:683-689.
47. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ. Maternal care associated with methylation of the estrogen receptor-α1b promoter and estrogen receptor-α expression in the medial preoptic area of female offspring. Endocrinology 2006;147:2909-2915. (Pubitemid 43764626)
48. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004;7:847-854.
49. Westberry JM, Prewitt AK, Wilson ME. Epigenetic regulation of the estrogen receptor α promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 2008;152:982-989.
50. Plachot C, Lelievre SA. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium. Exp Cell Res 2004;298:122-132. (Pubitemid 38887312)
51. Tsellou E, Michailidi C, Pafiti A, Troungos C. DNA methylationindependent regulation of p16 in epithelial cells during mouse mammary gland development. Epigenetics 2008;3:143-148.
52. Taylor SM. p53 and deregulation of DNA methylation in cancer. Cellscience Reviews 2006;2:82-93.
53. Sansom OJ, Maddison K, Clarke AR. Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat Clin Pract Oncol 2007;4:305-315. (Pubitemid 46758788)
54. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007;1775:138-162.
55. Dodge JE, Okano M, Dick F, et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 2005;280:17986-17991. (Pubitemid 41389041)
56. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
57. Dobosy JR, Roberts JL, Fu VX, Jarrard DF. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 2007;177:822-831.